Rapinno Pharma Labs Private Limited
About Rapinno Pharma Labs Private Limited
Data last updated:
Rapinno Pharma Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the software development and support services segment of the technology and IT services sector. It was incorporated on 26 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2020PTC143202.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jyothi Yalavarthi (Managing Director) and Naresh Velaga.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 101/B 1st Floor Srisampada Arcade – III Khajaguda Behind Andharabank Manikonda, Hyderabad, Telangana, India – 500008.
As per the financials filed for FY 2022, the company reported a revenue of ₹72,000. For the same year it recorded a net profit of ₹23,362 (net margin 32.4%) and EBITDA of ₹32,991 (EBITDA margin 45.8%).
Company details
Contact details
Rapinno Pharma Labs Private Limited's registered office is in Hyderabad, Telangana.
- Registered Address101/B 1st Floor Srisampada Arcade – III Khajaguda Behind Andharabank Manikonda, Hyderabad, Telangana, India – 500008
- IndustryInformation Technology, Software Development & Support Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rapinno Pharma Labs is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Rapinno Pharma Labs Private Limited, buy the company report.
Financials of Rapinno Pharma Labs Private Limited
FY 2022 filings availableRapinno Pharma Labs Private Limited reported revenue of ₹72,000 for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹32,991 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹23,362 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 45.8% | |
| Net Profit Margin | 32.4% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Rapinno Pharma Labs Private Limited, buy the company report.
Board of directors of Rapinno Pharma Labs Private Limited
Rapinno Pharma Labs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Velaga Also directs: Beecity Builders LLP, Ncity Builders LLP, Kumbhasthala Global Spaces Private Limited and 2 more | Director | 26 Aug 2020 | 6 Years 2 Months | Current |
| Jyothi Yalavarthi | Managing Director | 08 Aug 2022 | 4 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Rapinno Pharma Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rapinno Pharma Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rapinno Pharma Labs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rapinno Pharma Labs Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Jyothi Yalavarthi was appointed as Managing Director on 08 Aug 2022.
Frequently asked questions
Rapinno Pharma Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in software development and support services, within the information technology industry. It was incorporated on 26 August 2020 (6+ years old) and is registered under CIN U24299TG2020PTC143202.
Rapinno Pharma Labs has 2 current directors:
- Jyothi Yalavarthi - Managing Director
- Naresh Velaga - Director
The latest financial statements of Rapinno Pharma Labs on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Rapinno Pharma Labs is U24299TG2020PTC143202. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rapinno Pharma Labs was incorporated on 26 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Jyothi Yalavarthi was appointed as Managing Director on 08 Aug 2022. Pavan Kumar Kodedela ceased to be Director on 08 Aug 2022. Naresh Velaga was appointed as Director on 26 Aug 2020.
The registered office of Rapinno Pharma Labs is at 101B 1st Floor Srisampada Arcade – III Khajaguda Behind Andharabank Manikonda, Hyderabad, Telangana, India – 500008.
Rapinno Pharma Labs operates in the information technology industry, in the software development and support services segment.
Rapinno Pharma Labs can be reached at its registered office: 101B 1st Floor Srisampada Arcade – III Khajaguda Behind Andharabank Manikonda, Hyderabad, Telangana, India – 500008.
Rapinno Pharma Labs is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.